CN Stock MarketDetailed Quotes

300529 Jafron Biomedical

Watchlist
  • 25.80
  • -0.44-1.68%
Market Closed Aug 9 15:00 CST
20.83BMarket Cap29.28P/E (TTM)

Jafron Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jafron Biomedical Earnings Date

Currency: CNY

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

751.29M

+70.91%
Net Income(YoY)

266.83M

+233.73%
Analyst Rating

Strong Buy

Aug 10, 2024

Jafron Biomedical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3473.838M / 554.000M--
--2023/Q2439.586M / 628.000M--
--2023/Q1572.558M / 632.000M--
--2021/Q1578.901M / 578.900M--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3473.838M / 554.000M--
--2023/Q2439.586M / 628.000M--
--2023/Q1572.558M / 632.000M--
--2021/Q1578.901M / 578.900M--
--------

Unlock Free Earnings Estimates

Jafron Biomedical Earnings Reports

  • Jafron Biomedical: Summary of Half-Year Report in 2024.

    Aug 7 12:00 ET

  • Jafron Biomedical: Half-year report for the year 2024.

    Aug 7 12:00 ET

  • Jafron Biomedical: 2024 Interim Performance Forecast

    Jul 8 06:36 ET

  • Jafron Biomedical: 2023 Annual Report Summary

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 10, 2024

    Strong Buy

    • Strong Buy

      77.78%

    • Buy

      22.22%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg